Publications

Koirala A, Winkler NE, Prasad SA, Hirani R, Baker J, Hueston L, O'Sullivan M, Stepien S, Hoad V, Kok J, Gosbell IB, Kaur G, Jackson J, Snelling TL, Dwyer DE, Irving DO, Macartney K. Seroprevalence of Japanese encephalitis virus and other flavivirus-specific antibodies among Australian blood donors following a novel epidemic spread of Japanese encephalitis virus: a cross-sectional study. BMJ Open 2026;16:e117510. doi: 10.1136/bmjopen-2026-117510. [Full Text]

Arkell P, de Neri Machado F, Vicco A, Cox VM, Tanesi MY, Ximenes D, Hinsley W, Bosco F, Gomes N, Oakley T, Solano V, Sheridan SL, David M, Amaral S, Freitas L, Draper AD, Sarmento N, Soares da Silva E, Alves L, Ferguson N, Donnelly CA, Yan J, Francis JR, Dorigatti I, Martins N. Sero-catalytic and spatial modeling of dengue virus force of infection in Timor-Leste. Nature Communications 2026. doi: 10.1038/s41467-026-76716-9 . [Full text - Epub]

Koirala A, Attard C, Skowno J. Anesthesia as a partner in public health: enabling national pediatric SARS-CoV-2 serosurveillance in Australia. Anesthesiology 2026. doi: 10.1097/ALN.0000000000006317 . [Abstract [Epub]]

Liu S, Wu D, Ye S, Xiao Y, Wu M, Chen S, Zhang X, Guo L, Zhang Q, Zhou Y, Wu X, Yang Q, Xiao R, Zhang J, Feng X, Wang J, Shi X, Zhang X, Xu J, Shao J, Tang S, Liu Q. Corrigendum to "HPV vaccination policies and implementation for adolescents in low- and middle-income countries: a scoping review" . Lancet Regional Health Western Pacific 2026 ;72:101919. doi: 10.1016/j.lanwpc.2026.101919 . [Full Text]

Chang JI, Dale RC, Mohammed S, Burrell R, Phan K, Blyth CC, Carr JP, Clark JE, Crawford NW, Francis JR, Marshall H, McMullan B, Carey E, Wood N, Jones CA, Britton PN; PAEDS Network (Macartney K). Infection triggered encephalopathies in Australian children: a national multicentre case series 2013-2024. Journal of Pediatrics 2026:115291. doi: 10.1016/j.jpeds.2026.115291 . [Full Text]

Croker Z, McLure A, Lambert S, Quinn H, Pillsbury A, Macartney K, McIntyre P, Beard F. Estimating current susceptibility to measles in Australia following sustained measles elimination. Australia and New Zealand Journal of Public Health 2026;50:100577. doi: 10.1016/j.anzjph.2026.100577 . [Full Text]

Lu C, Barr IG, Lambert SB, Mengersen K, Wang L, Yang W, Li Z, Vardoulakis S, Bambrick H, Hu W. COVID-19 disruption and rebound of respiratory syncytial virus hospital burden in Australia: a national interrupted time-series analysis. Journal of Infection and Public Health 2026;19:103337. doi: 10.1016/j.jiph.2026.103337 . [Full Text]

Nguyen T, Tay EC, Dymock M, Snelling TL, Dawes L, Marsh J, Wu Y, Leeb A, Wood N, Deng L. Short-term safety of concomitant meningococcal B and national immunisation program vaccines in infants aged < 15 Months: a survey-based surveillance study. Medical Journal of Australia 2026;224:e70297. doi: 10.5694/mja2.70297. [Full Text]

Imai-Boulter C, Li-Kim-Moy J, Chiu C, Jayasinghe S, Macartney K. Respiratory syncytial virus disease burden and evidence gaps in Australia before immunisation introduction: a retrospective population-based study using 2016-2019 hospitalisation and 2023 laboratory surveillance data. Medical Journal of Australia 2026;224:e70289. doi: 10.5694/mja2.70289. [Full Text]

Wang X, Williams P, Sharma K, Quinn H, Jayasinghe S, Chiu C, Macartney K, Flanagan K, Cooper K, Teh B, Giles M, Crawford N. ATAGI targeted review 2025: immunisation considerations for immunocompromised people in Australia. Communicable Diseases Intelligence (2018) 2026;50. doi: 10.33321/cdi.2026.50.056. [Full Text]